Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Trial of Dimethyl Fumarate, Temozolomide, and Radiation Therapy in Glioblastoma Multiforme

NCT02337426 is registered in ClinicalTrials.gov with Virginia Commonwealth University as lead sponsor.

NCT NCT02337426
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02337426 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Trial of Dimethyl Fumarate, Temozolomide, and Radiation Therapy in Glioblastoma Multiforme
Lead sponsor
Virginia Commonwealth University
Phase
Phase 1
Overall status
Completed
Start date
February 13, 2015
Completion date
November 9, 2017
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adult brain glioblastoma, adult giant cell glioblastoma, adult gliosarcoma